Contraceptive Research and Development Looking to the Future (1996) / Chapter Skim
Currently Skimming:
8 Recommendations
8 Recommendations
Pages 341-348
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 341... ...
Thus, the Institute of Medicine and this study committee were challenged not only with investigating what the new science had to offer, but with examining the climate for collaboration between the public and private sectors in translating those offerings so as to meet the need and demand for new contraceptive options. Throughout its work, the committee sought to frame its exploration and possible response to these issues around contraceptive research and development in a way that might offer a fresh outlook on the subject.
|
From page 342... ...
THE PROSPECTS OF THE SCIENCE Recommendation 1. The committee recommends that priorities for new research be assessed against the preference criteria presented in a new "womancentered agenda" and that existing public-sector contraceptive research and development portfolios be reassessed similarly.
|
From page 343... ...
The committee recommends that, to make a full range of contraceptive products accessible to consumers and to increase demand for contraceptive products to something closer to the level of unmet need, there should be continued and sufficient government support of contraceptive services -- for males as well as females -- particularly for low-income individuals and particularly in developing countries. The committee also recommends that third-party payers, who bear the costs and may reap the benefits of the health status of their covered populations, include contraception as a covered service.
|
From page 344... ...
Recommendation 7. The committee recommends that consideration be given to a multilateral approach that would enlist the participation of public agencies and private philanthropic organizations toward support for an extension of the Global
|
From page 345... ...
The committee strongly endorses continued public sector support of, first, basic research in innovative areas of reproductive biology as a source of new leads for contraceptive research and development and, second, in the applied research that will bring the most promising leads to fruition.
|
From page 346... ...
The committee recommends that approval guidelines be developed as quickly as possible for the high-priority area of vaginal microbicides and spermicides, as a first step toward clarifying requirements for clinical trials and monitoring of novel contraceptives in general. A consensus conference on this topic is recommended, perhaps convened by the World Health Organization.
|
From page 347... ...
Change came from several sources -- from a surge of discovery in the science, from legislative action that modified public policy, from leadership at national and international policy levels, and from the decision of a major international donor to seek outside guidance in assessing its processes and their impact. This does not mean that the same amount of time will be needed for improvement in the contraceptive landscape, nor will the solutions be the same.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.